The Short-Term MBT Project
MBT-RCT
Short-term Versus Long-term Mentalization-based Therapy for Outpatients With Subthreshold or Diagnosed Borderline Personality Disorder: a Randomized Clinical Trial
1 other identifier
interventional
166
1 country
1
Brief Summary
The study will evaluate the benefitial and harmful effects of short-term (20 weeks) compared to long-term (14 months) mentalization-based therapy for outpatients with subthreshold or diagnosed borderline personality disorder.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started Sep 2018
Longer than P75 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 14, 2018
CompletedFirst Posted
Study publicly available on registry
September 19, 2018
CompletedStudy Start
First participant enrolled
September 24, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2023
CompletedJanuary 12, 2024
January 1, 2024
4.2 years
September 14, 2018
January 11, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in severity of borderline personality disorder assessed with the Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD) interview
ZAN-BPD is an investigator-administered interview assessing change in severity of borderline personality disorder over time. Each of the nine DSM-5 criteria for borderline personality disorder are rated on a scale from 0-4, where 4 is the most severe, yielding a total score from 0-36.
Assessed at baseline, and at 8, 16 and 24 months post-randomization
Secondary Outcomes (4)
Change in functional impairmment assessed with the Work and Social Adjustment Scale (WSAS)
Assessed at baseline, and at 8, 16 and 24 months post-randomization
Change in quality of life assessed with the Short-Form Health Survey 36 (SF-36)
Assessed at baseline, and at 8, 16 and 24 months post-randomization
Change in global functioning assessed with the Global Assessment of Functioning (GAF)
Assessed at baseline, and at 8, 16 and 24 months post-randomization
Change in amount of self-harm incidents
Assessed at baseline, and at 8, 16 and 24 months post-randomization
Other Outcomes (1)
Change in psychiatric symptom distress assessed with the Symptom Checklist 90 (SCL-90)
Assessed at baseline, and at 8, 16 and 24 months post-randomization
Study Arms (2)
Short-term MBT
EXPERIMENTALThe experimental group is short-term mentalization-based therapy. The treatment program includes 20 weeks of mentalization-based group therapy with conjoined individual therapy every second week. The program also includes psychoeducation and individual caseformulations.
Long-term MBT
ACTIVE COMPARATORThe control group is long-term mentalization-based therapy. The treatment program includes 14 months of weekly mentalization-based group therapy with combined individual therapy every second week. The program also includes psychoeducation and individual caseformulations.
Interventions
Eligibility Criteria
You may qualify if:
- Age \>18 years
- Personality disorder(s) considered to be primary diagnosis/diagnoses
- A minimum of four DSM-5 criteria for borderline personality disorder
- Written informed consent
You may not qualify if:
- Possibility of a learning disability (IQ\<75)
- A diagnosis of schizotypal personality disorder or antisocial personality disorder
- Presence of a comorbid psychiatric disorder that requires specialist treatment elsewhere
- Current (past 2 months) substance dependance including alcohol
- Concurrent psychotherapeutic treatment outside the clinic
- \- Lack of informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stolpegaard Psychotherapy Centre, Mental Health Services, Capital Region of Denmark
Gentofte Municipality, 2820, Denmark
Related Publications (5)
Juul S, Jakobsen JC, Hestbaek E, Jorgensen CK, Olsen MH, Rishede M, Frandsen FW, Bo S, Lunn S, Poulsen S, Sorensen P, Bateman A, Simonsen S. Short-Term versus Long-Term Mentalization-Based Therapy for Borderline Personality Disorder: A Randomized Clinical Trial (MBT-RCT). Psychother Psychosom. 2023;92(5):329-339. doi: 10.1159/000534289. Epub 2023 Nov 7.
PMID: 37935133DERIVEDJuul S, Simonsen S, Poulsen S, Lunn S, Sorensen P, Bateman A, Jakobsen JC. Detailed statistical analysis plan for the short-term versus long-term mentalisation-based therapy for outpatients with subthreshold or diagnosed borderline personality disorder randomised clinical trial (MBT-RCT). Trials. 2021 Jul 28;22(1):497. doi: 10.1186/s13063-021-05450-y.
PMID: 34321051DERIVEDGibbon S, Khalifa NR, Cheung NH, Vollm BA, McCarthy L. Psychological interventions for antisocial personality disorder. Cochrane Database Syst Rev. 2020 Sep 3;9(9):CD007668. doi: 10.1002/14651858.CD007668.pub3.
PMID: 32880104DERIVEDStorebo OJ, Stoffers-Winterling JM, Vollm BA, Kongerslev MT, Mattivi JT, Jorgensen MS, Faltinsen E, Todorovac A, Sales CP, Callesen HE, Lieb K, Simonsen E. Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev. 2020 May 4;5(5):CD012955. doi: 10.1002/14651858.CD012955.pub2.
PMID: 32368793DERIVEDJuul S, Lunn S, Poulsen S, Sorensen P, Salimi M, Jakobsen JC, Bateman A, Simonsen S. Short-term versus long-term mentalization-based therapy for outpatients with subthreshold or diagnosed borderline personality disorder: a protocol for a randomized clinical trial. Trials. 2019 Apr 5;20(1):196. doi: 10.1186/s13063-019-3306-7.
PMID: 30953536DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Sebastian Simonsen, PhD
Sponsor-Investigator
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 14, 2018
First Posted
September 19, 2018
Study Start
September 24, 2018
Primary Completion
December 15, 2022
Study Completion
December 15, 2023
Last Updated
January 12, 2024
Record last verified: 2024-01